Tech Company Financing Transactions
Clarus Therapeutics Funding Round
Clarus Therapeutics closed a $31.5 million funding round on 6/14/2014. Investors included C-Bridge Capital, BioVeda Capital and Pavilion Capital Partners.
Transaction Overview
Company Name
Announced On
6/14/2014
Transaction Type
Debt
Amount
$31,500,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds from the financing will be used to help support the new drug application (NDA) approval process and commercialization of the Company's lead product candidate, REXTORO.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
555 Skokie Blvd. 340
Northbrook, IL 60062
USA
Northbrook, IL 60062
USA
Phone
Website
Email Address
Overview
Clarus Therapeutics is an emerging men s health specialty pharmaceutical company preparing for the commercial launch of REXTORO, our oral testosterone (T) replacement therapy.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert Dudley
Chief Financial Officer
Steven Bourne
Chief Medical Officer
Theodore Danoff
Browse more venture capital transactions:
Prev: 6/14/2014: Tinfoil Security venture capital transaction
Next: 6/14/2014: StickNFind venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs